Editor-in-Chief
He is a Professor of Pharmacology and Academic Head at the Shri Shankaracharya College of Pharmaceutical Sciences, Shri Shankaracharya Professional University, Bhilai, India. With more than 13 years of experience in pharmaceutical education, research, academic leadership, and scientific publishing, he has established himself as a distinguished scholar in pharmacology and translational pharmaceutical sciences. He earned his Ph.D. in Pharmacy and M.Pharm. in Pharmacology from Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India.
Dr. Choudhary’s research spans pharmacology, ocular therapeutics, drug discovery, nanotechnology-based drug delivery, pharmacovigilance, network pharmacology, molecular docking, experimental pharmacology, herbal therapeutics, and translational medicine. His work has significantly advanced the understanding of cataract pharmacotherapy, oxidative stress, hypertension-associated ocular disorders, natural product pharmacology, and innovative drug delivery systems. As the Coordinator of the ADR Monitoring Centre recognized by the Indian Pharmacopoeia Commission (PvPI), Government of India, he actively contributes to strengthening pharmacovigilance practices and medication safety.
An accomplished researcher, Dr. Choudhary has authored more than 55 peer-reviewed scientific publications, including over 35 papers indexed in Scopus and Web of Science, together with 20 book chapters, numerous patents, and internationally recognized research contributions. His work has received more than 700 citations, with a Google Scholar h-index of 14, reflecting his sustained impact on pharmaceutical sciences and biomedical research. He has successfully supervised numerous postgraduate and doctoral researchers while leading funded research projects and multidisciplinary collaborations in pharmacology, nanomedicine, and pharmaceutical innovation.
Beyond research, Dr. Choudhary is widely recognized for his leadership in higher education and scholarly communication. He serves on academic and institutional committees, acts as an active reviewer for several national and international journals, and has delivered numerous invited keynote lectures, expert talks, faculty development programmes, and workshops on pharmacology, drug discovery, pharmacovigilance, biostatistics, network pharmacology, and research methodology. His academic leadership has played an important role in mentoring young researchers and promoting a culture of scientific excellence and ethical research practices.
Co-Editors-in-Chief
Since 2024, Dr. Sagarika Majhi has been Professor at I.T.S. College of Pharmacy, Ghaziabad, India, with more than 18 years of academic and research experience in pharmaceutical sciences. She received her Ph.D. in Pharmaceutical Sciences from Swami Vivekanand Subharti University, Meerut, in 2024, following her M.Pharm. (Pharmacology) from Roland Institute of Pharmaceutical Sciences, Berhampur, in 2007 and B.Pharm. from J. L. Chaturvedi College of Pharmacy, Nagpur University, in 2005. She served as Associate Professor from 2022 to 2024 and Assistant Professor from 2011 to 2022 at I.T.S. College of Pharmacy, and previously as Lecturer at D.J. College of Pharmacy, Modinagar, from 2008 to 2011.
Her research interests include network pharmacology, molecular docking, pharmacokinetics and pharmacodynamics of herbal phytoconstituents, neuropharmacology, pharmacovigilance, cardiovascular and central nervous system disorders, dermatological disorders, diabetes, and in silico drug discovery. She has guided 22 M.Pharm. dissertations and 198 B.Pharm. projects and has extensive expertise in experimental pharmacology, behavioral pharmacology, biochemical evaluation, and preclinical screening of therapeutic agents.
Dr. Majhi has made significant contributions to pharmaceutical research through her publications in leading national and international journals, including journals published by Bentham Science, Elsevier, Springer Nature, Sage, and other reputed publishers. She serves as a reviewer for several international journals, including Heliyon, Phytomedicine, Applied Food Research, Clinical Traditional Medicine and Pharmacology, Pharmacological Research -- Modern Chinese Medicine, Current Traditional Medicine, and PharmaNutrition. She has also been appointed to the Editorial Review Board of Clinical Medicine Insights: Case Reports (Sage Publishing) and has contributed to numerous books and book chapters published by Springer and Cambridge Scholars Publishing.
Her research and innovation activities are further demonstrated by granted and published intellectual property, including an international patent, an Indian patent application, and an Indian design patent in the fields of medical devices, artificial intelligence, and nanomedicine. Today, the scientific production of Dr. Sagarika Majhi consists of more than 55 peer-reviewed publications, several scholarly books and book chapters, multiple patents, and extensive contributions to pharmaceutical education, pharmacology, pharmacovigilance, and translational research.
Dr. R. S. Ray is a Scientific Officer at the Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare (MoHFW), Government of India, with extensive experience in neuropharmacology, pharmacovigilance, drug safety, herbal medicines, and public health. He obtained his Ph.D. from the Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), where he specialized in neuropharmacology and neuroscience research. His research interests include neurodegenerative disorders, neuroinflammation, oxidative stress, pharmacovigilance, regulatory science, adverse drug reaction monitoring, and the pharmacological evaluation of herbal medicines.
Dr. Ray has made significant contributions to medicine safety and regulatory science through his active involvement in the Pharmacovigilance Programme of India (PvPI). His work focuses on strengthening pharmacovigilance systems, signal detection, risk assessment, drug safety surveillance, and pharmacovigilance education, thereby supporting evidence-based regulatory decision-making and public health.
His scientific contributions are documented through numerous peer-reviewed publications in high-impact international journals, including Critical Reviews in Food Science and Nutrition, Neuroscience & Biobehavioral Reviews, Biomedicine & Pharmacotherapy, Inflammopharmacology, Phytotherapy Research, Clinical Therapeutics, European Journal of Clinical Pharmacology, and the Indian Journal of Pharmacology. He has also authored book chapters on essential medicines, fixed-dose combinations, herbal medicines, and rational pharmacotherapy.
Today, the scientific production of Dr. R. S. Ray comprises numerous peer-reviewed publications and scholarly book chapters, with more than 1,100 citations to his work. His research has made important contributions to neuropharmacology, pharmacovigilance, regulatory science, and drug safety, establishing him as a recognized researcher in pharmaceutical sciences and public health.
Senior Executive Editor
Since 2021, Prof. (Dr.) Niranjan Kaushik has been Professor and Head of the Department of Pharmacy, School of Medical & Allied Sciences, Galgotias University, Greater Noida, India, with more than 18 years of experience in pharmaceutical education, research, and academic administration. He was Associate Professor from 2018 to 2021 and Assistant Professor from 2014 to 2017 at Galgotias University. Earlier, he served as Assistant Professor at Meerut Institute of Engineering & Technology, Meerut, from 2009 to 2014, and as Lecturer at Shri Gopi Chand College of Pharmacy, Baghpat, from 2007 to 2009. He obtained his Ph.D. in Pharmaceutical Chemistry from IFTM University, Moradabad, in 2017, following his M.Pharm. in Pharmaceutical Chemistry in 2007.
Prof. Kaushik has extensive expertise in medicinal chemistry, pharmaceutical chemistry, drug discovery, computer-aided drug design, molecular docking, nanotechnology, pharmaceutical analysis, and anticancer drug development. His research focuses on the design and synthesis of novel heterocyclic compounds, nanomedicine, computational drug discovery, and targeted therapeutic strategies for cancer, tuberculosis, neurodegenerative disorders, and other chronic diseases. He has also played an active role in academic leadership through NAAC and NBA accreditation processes and serves as a NAAC Assessor.
His research achievements are further demonstrated by numerous patents, funded research projects, and books published by leading international publishers, including CRC Press (Taylor & Francis), Springer Nature, and I. K. International Publishing House. He has supervised several Ph.D. and M.Pharm. scholars and serves as reviewer and editorial board member for several international journals in medicinal chemistry, pharmaceutical sciences, and drug discovery.
Today, the scientific production of Prof. (Dr.) Niranjan Kaushik consists of more than 55 peer-reviewed publications, including 40 Scopus-indexed articles, three books, numerous international book chapters, several Indian and international patents, Google Scholar citations exceeding 630, an h-index of 11, and an i10-index of 12, reflecting his significant contributions to medicinal chemistry, pharmaceutical sciences, nanomedicine, and computational drug discovery.
Deputy Editor
Since 2024, Dr. Prashant Kumar has been Associate Professor at SRM Modinagar College of Pharmacy, Faculty of Medicine & Health Sciences, SRM Institute of Science and Technology (Deemed to be University), NCR Campus, Delhi-Meerut Road, Modinagar, Ghaziabad, Uttar Pradesh 201204, India, with more than 15 years of academic and industrial experience in pharmaceutics, nanotechnology, and novel drug delivery systems. He obtained his Ph.D. in Pharmaceutics from Kumaun University in 2019, following his M.Pharm. in Pharmaceutics from Uttar Pradesh Technical University, Lucknow, in 2011 and B.Pharm. in 2009. Prior to joining SRM Institute of Science and Technology, he served as Associate Professor at Teerthanker Mahaveer University, Moradabad, and Rama University, Kanpur, and as Assistant Professor at PSIT, Kanpur.
His research interests include pharmaceutical nanotechnology, nanoparticulate drug delivery systems, nanostructured lipid carriers, targeted drug delivery, herbal cosmeceuticals, transdermal drug delivery, artificial intelligence in drug design, and formulation optimization. He has extensive experience in the development of nano drug delivery systems using Design of Experiments (DoE), along with in vitro and in vivo evaluation of optimized formulations. He has successfully supervised three Ph.D. scholars, with several additional doctoral candidates currently pursuing research under his guidance.
His scientific contributions are documented through more than 70 plus peer-reviewed publications in SCI and Scopus-indexed journals, covering nanotechnology, cancer therapeutics, targeted drug delivery, herbal formulations, cosmeceuticals, and pharmaceutical sciences. His research has received wide recognition, particularly in the fields of nanomedicine and drug-resistant cancer therapy. He is also the inventor and co-inventor of granted and published patents related to pharmaceutical formulations and drug delivery technologies and serves as a life member of the Indian Pharmaceutical Graduate Association (IPGA) and a registered pharmacist under the Pharmacy Council of India.
Today, the scientific production of Dr. Prashant Kumar consists of more than 70plus peer-reviewed publications, multiple patents, funded research projects, and over 1694 Google Scholar citations, reflecting his significant contributions to pharmaceutics, nanotechnology, targeted drug delivery, and herbal cosmeceutical research.
Senior Associate Editors
He is the Director of Research and Development – Molecular Biology at NOWDiagnostics, USA, where he leads the development of next-generation over-the-counter (OTC) molecular diagnostic technologies for decentralized healthcare. He earned his Ph.D. in Genetic Engineering and Biotechnology from the University of Baghdad and further advanced his research career at the University of Arkansas, USA, specializing in molecular biology, bioprocess engineering, and applied biotechnology.
Dr. Aljewari is an accomplished molecular diagnostics scientist whose research focuses on rapid nucleic acid-based detection technologies, molecular assay development, infectious disease diagnostics, and translational biotechnology. His expertise includes loop-mediated isothermal amplification (LAMP), lyophilized reagent systems, molecular diagnostics, sample-to-answer technologies, and the development of innovative point-of-care diagnostic platforms that combine laboratory-level sensitivity with accessibility and ease of use.
As Director of R&D, he oversees the design and development of advanced molecular diagnostic products for infectious disease detection and actively contributes to the translation of cutting-edge biotechnology into commercially viable healthcare solutions. His work has led to multiple intellectual property filings in the field of rapid molecular diagnostics and innovative nucleic acid detection technologies.
In addition to his industrial research leadership, Dr. Aljewari is committed to scientific mentorship, research innovation, and the advancement of molecular diagnostics through interdisciplinary collaboration. His expertise spans molecular biology, genetic engineering, biotechnology, assay development, bioprocess engineering, and translational biomedical research, supporting the development of next-generation diagnostic technologies for global healthcare.
As an Associate Editor of the Journal of Pharmacological Horizons, Dr. Aljewari contributes his extensive expertise in molecular diagnostics, biotechnology, and translational biomedical research to support rigorous peer review, uphold publication ethics, and promote high-quality scientific publishing within the global research community.
Prof. (Dr.) Rahul Shukla is Professor of Pharmacy, Director of the Future Institute of Pharmacy, Controller of Examinations, Dean (Pharmacy), and IQAC Coordinator at Future University, Bareilly, India. He has over 21 years of academic, research, and higher education leadership experience, having served in several key administrative positions including Registrar (In-Charge), Dean (Academic), Principal, Professor, Associate Professor, Assistant Professor, and Controller of Examinations across leading Indian universities and institutions.
Dr. Shukla received his Ph.D. in Pharmacy from Bundelkhand University, Jhansi, India, in 2013 after completing his M.Pharm. (Pharmacognosy) from The Oxford College of Pharmacy, Rajiv Gandhi University of Health Sciences, Bengaluru, in 2008 and B.Pharm. from Rajiv Gandhi University of Health Sciences in 2005.
His research interests include pharmacognosy, phytochemistry, natural product drug discovery, medicinal plants, pharmaceutical analysis, herbal formulations, nanotechnology-based drug delivery systems, pharmacological screening, formulation development, and pharmaceutical quality assurance. His work also encompasses university governance, quality assurance, accreditation, outcome-based education, and academic administration.
Prof. Shukla has played a leading role in institutional development, academic governance, and regulatory compliance involving UGC, AICTE, PCI, NAAC, NIRF, NBA, AISHE, NCISM, BCI, INC, and other national regulatory agencies. He has successfully contributed to the establishment of IQAC, Ph.D. programmes, incubation and start-up ecosystems, research governance frameworks, institutional policies, accreditation documentation, and quality management systems.
He has published more than 69 research and review articles in national and international peer-reviewed journals and has authored books, edited conference proceedings, obtained multiple patents, supervised Ph.D. scholars, organized numerous international conferences, national conferences, workshops, and faculty development programmes, and delivered invited lectures at academic institutions across India. He also serves on the editorial boards of several scientific journals and is actively involved in peer review and academic publishing.
Prof. Shukla has received several recognitions for his academic and research contributions, including the Outstanding Scientist Award (2021), the India Elite Education & Institutional Excellence Award (2024), the Outstanding Educator Award (2024), and the Shikshak Ratan Samman (2025). His scholarly profile includes a Google Scholar h-index of 10, an i10-index of 10, and over 460 citations, reflecting his sustained contributions to pharmaceutical sciences, pharmacognosy, phytochemistry, higher education leadership, and research.
Since 2024, Dr. Iti Chauhan has been Professor in the Department of Pharmaceutics at I.T.S. College of Pharmacy, Ghaziabad, India, with more than 18 years of experience in pharmaceutical education, research, and formulation development. She was Associate Professor from 2022 to 2024, Assistant Professor from 2010 to 2022, and Lecturer from 2007 to 2010 at I.T.S. College of Pharmacy. She obtained her Ph.D. in Pharmaceutical Sciences from Swami Vivekanand Subharti University, Meerut, in 2024, following her M.Pharm. from Raj Kumar Goel Institute of Technology, Ghaziabad, in 2007 and B.Pharm. from the Institute of Engineering and Technology, Bareilly, in 2005.
Her research interests include pharmaceutics, nanotechnology, lipid-based drug delivery systems, nanostructured lipid carriers, transdermal and dermal drug delivery, pharmaceutical nanotechnology, herbal formulations, cosmetic science, pharmacovigilance, and formulation optimization. She has extensive expertise in the development, characterization, and optimization of lipid nanoparticles and topical drug delivery systems and has successfully guided numerous postgraduate research projects in pharmaceutics.
Dr. Chauhan has made significant contributions to pharmaceutical sciences through her publications in leading international journals and book chapters published by Elsevier, Wiley, Cambridge Scholars Publishing, and Bentham Science Publishers. She has also contributed to pharmaceutical education through textbooks and scholarly books and serves as reviewer for journals published by Elsevier, Bentham Science Publishers, and other international publishers. She is currently associated with several editorial initiatives, including forthcoming books and thematic issues in pharmaceutical sciences.
Her research achievements are further demonstrated by granted national and international patents, including innovations in solid lipid nanoparticles and medical diagnostic technologies. Today, the scientific production of Dr. Iti Chauhan consists of more than 75 peer-reviewed publications, several books and international book chapters, multiple patents, a Google Scholar h-index of 15, a Scopus h-index of 10, and sustained contributions to pharmaceutics, nanotechnology, lipid-based drug delivery systems, cosmetic science, and pharmaceutical research.
Associate Editors
Ph.D. candidate in the Department of Pharmaceutical Sciences at Texas A&M University, College Station, Texas, USA. His doctoral research focuses on medicinal chemistry, computer-aided drug discovery, and the design of novel small-molecule therapeutics targeting Heme Oxygenase-1 (HO-1) and NR4A1 using PROTAC technology. His research integrates synthetic medicinal chemistry with computational modeling to accelerate the discovery of innovative therapeutic agents.
Mr. Nwankwo obtained his Master of Science in Chemistry from Prairie View A&M University, Texas, where his research focused on biomass conversion, catalytic hydrolysis of cellulose, and sustainable chemical processes. He earned his Bachelor of Science in Biochemistry from Abia State University, Nigeria. His scientific expertise spans medicinal chemistry, chemical biology, computational drug design, molecular docking, molecular dynamics simulations, QSAR, pharmacophore modeling, ADMET profiling, synthetic organic chemistry, analytical chemistry, and pharmaceutical biotechnology.
His scientific contributions include an extensive publication record comprising more than 20 peer-reviewed research and review articles published in internationally recognized journals, along with book chapters, media publications, and a U.S. patent application for selective Heme Oxygenase-1 inhibitors. His research addresses medicinal chemistry, natural products, pharmacology, oncology, biotechnology, and computational drug discovery, reflecting a multidisciplinary approach to pharmaceutical research.
Beyond his research, Mr. Nwankwo has served as a Graduate Teaching Assistant at Texas A&M University and previously worked as a Graduate Research Assistant at Prairie View A&M University and as a Laboratory Technician Intern at BASF Corporation. He is an active member of several prestigious scientific organizations, including the Royal Society of Chemistry (RSC), the American Association of Pharmaceutical Scientists (AAPS), the American Chemical Society (ACS), and the American Society for Biochemistry and Molecular Biology (ASBMB). He has also delivered invited keynote and plenary lectures at international scientific conferences and contributes to scholarly publishing as a peer reviewer for international journals.
Prof. Dr. Amit Lather is Professor of Pharmacology at Hindu College of Pharmacy, Sonipat, Haryana, India. He has more than 14 years of academic, research, and administrative experience in pharmaceutical sciences, with expertise spanning pharmacology, drug discovery, molecular modeling, computational drug design, medicinal chemistry, microbiology, and pharmaceutical research.
He earned his Ph.D. in Pharmaceutical Sciences from Maharshi Dayanand University, Rohtak, India, in 2021. His doctoral research focused on the design, development, and evaluation of novel glucosamine-6-phosphate synthase inhibitor-based preservatives. He completed his M.Pharm. in Pharmacology from Shobhit University, Meerut, in 2011 and obtained his B.Pharm. from Kurukshetra University in 2009.
Prof. Lather's research interests include pharmacology, computer-aided drug design, molecular docking, molecular dynamics simulation, artificial intelligence in drug discovery, antimicrobial drug development, natural products, pharmaceutical preservatives, neuropharmacology, diabetic complications, wound healing, and translational pharmaceutical research. His work integrates computational and experimental approaches for identifying novel therapeutic agents and pharmaceutical formulations.
Throughout his academic career, he has served in several leadership roles, including Professor, Associate Professor, Head of the Department of Pharmacology, Research Coordinator, Proctor, Examination Superintendent, Research Supervisor, and Member of accreditation and quality assurance committees. He has actively contributed to institutional development, research management, NIRF, NBA, and NAAC-related activities, postgraduate education, and research mentoring.
Prof. Lather has supervised Ph.D., M.Pharm., and undergraduate research projects and has contributed extensively to scientific literature. He has authored and co-authored numerous research articles published in high-impact international journals, including publications in Scientific Reports, BMC Chemistry, Current Pharmaceutical Design, Current Topics in Medicinal Chemistry, Current Drug Discovery Technologies, Planta Medica, and several other SCI, SCIE, Web of Science, and Scopus-indexed journals. He has also authored multiple book chapters published by Springer, Academic Press, and other international publishers, and holds several national and international patents related to pharmaceutical technologies, molecular docking devices, artificial intelligence applications, and biomedical devices.
He is a Council Member of the Indian Pharmaceutical Association (IPA), a Life Member of the Association of Pharmaceutical Teachers of India (APTI) and the Indian Pharmacy Graduates' Association (IPGA), and is registered with the Haryana State Pharmacy Council. He also serves as Member Secretary and Scientist In-charge of an IAEC-approved animal facility and has actively participated in research ethics, regulatory affairs, and laboratory animal science.
Prof. Lather regularly serves as a resource person, invited speaker, conference organizer, reviewer, and academic mentor. His research contributions continue to advance pharmaceutical sciences through interdisciplinary approaches combining pharmacology, computational biology, artificial intelligence, and translational drug discovery.
Since 2024, Satendra Kumar has been Assistant Professor at SRM Modinagar College of Pharmacy, SRM Institute of Science and Technology (Deemed to be University), Delhi-NCR Campus, Modinagar, India, with more than eight years of teaching and research experience in pharmaceutical sciences. Previously, he served as Assistant Professor at Galgotias University, Greater Noida, Future Institute of Pharmacy, Bareilly, and Monad University, Hapur. He obtained his M.Pharm. in Pharmaceutical Chemistry from IFTM University, Moradabad, in 2018 and B.Pharm. from IFTM University in 2016. He is currently pursuing his Ph.D. in Pharmaceutical Sciences at Galgotias University, where his research focuses on the design, synthesis, and biological evaluation of quinoline--isonicotinohydrazide derivatives for antitubercular drug discovery.
His research interests include medicinal chemistry, computer-aided drug design, molecular docking, artificial intelligence in drug discovery, nanotechnology, anti-tubercular drug discovery, heterocyclic chemistry, and computational medicinal chemistry. He has actively contributed to academic quality assurance through NBA, NAAC, and NIRF accreditation activities and has served as PCI Coordinator, Course Coordinator, Sports Coordinator, and Mentor.
His scientific contributions are documented through peer-reviewed publications in international journals, including the Journal of Molecular Structure, Recent Advances in Computer Science and Communications, Pharmaceutical Nanotechnology, Current Cancer Therapy Reviews, European Journal of Medicinal Chemistry Reports, Asian Journal of Chemistry, and other Scopus- and Web of Science-indexed journals. He has also authored several book chapters published by Springer Nature, Bentham Science Publishers, Apple Academic Press (CRC Press/Taylor & Francis), and other international publishers. His innovation activities are further demonstrated by multiple published patents and one granted Indian design patent in the areas of pharmaceutical technologies, molecular docking, nanotechnology, and drug delivery systems.
Today, the scientific production of Satendra Kumar consists of research articles, review articles, book chapters, patents, conference abstracts, and ongoing translational research in medicinal chemistry, artificial intelligence, nanotechnology, and anti-tubercular drug discovery, reflecting his growing contributions to pharmaceutical sciences and computational drug design.
Assistant Editors
He is currently an Assistant Professor at the University Institute of Pharmaceutical Sciences, Chandigarh University, Punjab, India. He earned his B.Pharm. with First Division and Distinction from Invertis University, Bareilly, Uttar Pradesh, followed by an M.Pharm. in Pharmaceutics from NIMS University Rajasthan, Jaipur. He is currently pursuing his Ph.D. in Pharmaceutical Sciences at Chitkara University, Rajpura, Punjab.
His research interests include advanced drug delivery systems, pharmaceutical formulation, nanotechnology, computational pharmaceutics, quality by design (QbD), targeted drug delivery, tuberculosis therapeutics, cancer nanomedicine, artificial intelligence in pharmaceutical sciences, and computer-aided drug design.
In recognition of his research contributions, he received the Young Scientist Award in January 2025 from the International Organizing Committee. His scholarly work includes more than 50 peer-reviewed publications, comprising review and research articles, along with eight academic textbooks for Diploma, Undergraduate, and Postgraduate Pharmacy education. He has also contributed to several book chapters and scientific publications with internationally recognized publishers and journals indexed in major academic databases.
Mr. Pal has actively participated in numerous national and international scientific conferences, faculty development programmes, workshops, and academic events, including international meetings held in the United States and the United Kingdom. His innovation portfolio includes seven granted Indian Design Patents, twenty-one international UK patents, and three granted copyrights, demonstrating his commitment to pharmaceutical innovation and intellectual property development.
He serves as a reviewer for more than 25 international peer-reviewed journals and has been a member of the editorial boards of several scientific journals. His research has received over 320 citations, with a Google Scholar h-index of 12, reflecting his growing impact in pharmaceutical sciences. Through his research, editorial activities, and academic contributions, he continues to advance the fields of pharmaceutics, nanomedicine, drug delivery, and translational pharmaceutical research.
Since 2025, Shubham Tomar has been serving as Pharmacovigilance Technical Data Associate (PV-TDA) at the Central Drugs Standard Control Organization (CDSCO Headquarters), Ministry of Health & Family Welfare, Government of India, New Delhi. Previously, he served as Pharmacovigilance Associate at the National Coordination Centre--Pharmacovigilance Programme of India (NCC-PvPI), Indian Pharmacopoeia Commission, Ghaziabad, from 2022 to 2025. He obtained his M.Pharm. in Pharmacology from GLA University, Mathura, in 2022 after completing his B.Pharm. from Dr. A.P.J. Abdul Kalam Technical University, Lucknow, in 2020. He has over three years of experience in regulatory pharmacovigilance, drug safety evaluation, and pharmaceutical research.
His research interests include pharmacovigilance, drug safety, pharmacoepidemiology, neuropharmacology, neurodegenerative disorders, signal detection, aggregate safety reporting, risk management plans, adverse event assessment, and regulatory sciences. At CDSCO, he is actively involved in the scientific evaluation of Periodic Safety Update Reports (PSURs), Periodic Benefit-Risk Evaluation Reports (PBRERs), Risk Management Plans (RMPs), vaccine safety surveillance, Reference Safety Information (RSI), pharmacovigilance inspections, AEFI assessment, and regulatory dossier evaluation under the Drugs and Cosmetics Act and NDCT Rules, 2019.
His scientific contributions are documented through peer-reviewed research and review publications in internationally recognized journals, including ACS Chemical Neuroscience, Molecular Biology Reports, Molecular Neurobiology, Neurological Sciences, Current Nutraceuticals, and Current Cosmetic Science, covering pharmacovigilance, neuropharmacology, neurodegeneration, and drug safety. He has also authored a textbook on pharmacovigilance, contributed international book chapters, and developed innovations protected through multiple Indian design patents related to neurological disorder detection and biosensor technologies.
Today, the scientific production of Shubham Tomar consists of peer-reviewed research and review articles, a textbook, international book chapters, multiple Indian design patents, invited lectures, and regulatory contributions, reflecting his growing expertise in pharmacovigilance, regulatory affairs, neuropharmacology, drug safety, and translational pharmaceutical research.
She is a Content Expert and Senior Editorial Assistant at Crimson Interactive, where she contributes to scholarly publishing, editorial strategy, scientific communication, and publication ethics. She holds an M.Sc. in Biochemistry from SIES College, Mumbai, a Postgraduate Diploma in Bioinformatics from St. Xavier’s College, Mumbai, and a B.Sc. in Microbiology and Biochemistry.
Her professional expertise spans academic publishing, peer review management, editorial quality assurance, medical communication, scientific writing, AI-assisted publishing, publication ethics, and digital content strategy. She has extensive experience developing educational resources, webinars, newsletters, conference materials, and editorial content while ensuring compliance with international publishing standards and ethical guidelines.
Before her current role, she served as Associate Content Expert and Editorial Assistant, and has also worked as a Medical Content Writer – Life Sciences and Website Content Writer for Trinka.ai. Her research experience includes work on EGFR in lung cancer at Tata Memorial Hospital, Mumbai, along with contributions to scientific writing, peer review, and bioinformatics research projects.
Ms. Nair has authored peer-reviewed scientific publications in biochemistry and microbiology and has presented her work at internationally recognized conferences, including the Society for Scholarly Publishing (SSP) Annual Conference and the Year of Open Science Conference. Her presentations have focused on scholarly publishing, publication ethics, artificial intelligence, open science, and research integrity.
She is actively involved in the global scholarly communication community through professional memberships with the Society for Scholarly Publishing (SSP) and the International Science Council (ISC). Her expertise in editorial workflows, scientific communication, publication ethics, and academic content development supports the journal’s commitment to maintaining high standards of scientific quality, transparency, and research integrity.
Managing Editor
Ritu Raj Kumar serves as Managing Editor, overseeing the day-to-day editorial operations, manuscript workflow, and production coordination of the journal.
Section Editors
He is an Associate Professor in the Department of Pharmacy at Shri Venkateshwara University, India. His academic and research career is dedicated to advancing pharmaceutical sciences through interdisciplinary research in drug discovery, medicinal chemistry, pharmacology, and translational medicine.
His research interests encompass drug discovery and development, medicinal chemistry, pharmacology, neuropharmacology, pharmacogenomics, toxicology, anticancer drug research, infectious disease pharmacology, drug metabolism, ethnopharmacology, clinical pharmacy, pharmaceutical analysis, pharmaceutics, pharmacognosy, drug delivery systems, nanomedicine, biotechnology, molecular modeling, artificial intelligence in drug discovery, pharmacovigilance, precision medicine, herbal medicine, and pharmaceutical quality assurance. His multidisciplinary expertise supports the development of innovative therapeutic strategies and evidence-based pharmaceutical research.
Dr. Nitin has authored 13 scientific publications, including six publications indexed in Scopus/Web of Science, and has established a growing research profile with an h-index of 3. His scholarly contributions reflect his commitment to pharmaceutical innovation, scientific excellence, and translational research across diverse areas of biomedical sciences.
In addition to his research activities, he actively participates in the peer-review process and contributes to maintaining the quality and integrity of scientific publishing. His expertise enables the critical evaluation of manuscripts covering medicinal chemistry, pharmacology, pharmaceutics, biotechnology, nanomedicine, and related pharmaceutical disciplines.
Since 2022, Bhawna Sharma has been serving as Assistant Professor in the Department of Pharmaceutics at Dr. K. N. Modi Institute of Pharmaceutical Education and Research, Modinagar, India. She obtained her M.Pharm. from I.T.S. College of Pharmacy, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, in 2022 and completed her B.Pharm. from the same institution in 2020. She is currently pursuing her Ph.D. in Pharmaceutical Sciences at Dr. K. N. Modi University, Newai, Rajasthan. She has experience in teaching undergraduate and postgraduate pharmacy courses and has actively contributed to academic administration, accreditation activities, and research supervision.
Her research interests include pharmaceutical nanotechnology, lipid-based drug delivery systems, nanostructured lipid carriers, proliposomes, bilosomes, topical and transdermal drug delivery, herbal formulations, computational drug repositioning, cosmetic science, and formulation development. She has guided postgraduate research projects focusing on nanostructured lipid carrier-based formulations for wound healing, sunscreen, antimicrobial therapy, and topical drug delivery.
Her scientific contributions are documented through numerous peer-reviewed publications in internationally recognized journals, including Drug Delivery Letters, Current Nanomedicine, Nanoscience & Nanotechnology-Asia, Current Cosmetic Science, Current Functional Foods, Current Drug Research Reviews, Drug Metabolism and Bioanalysis Letters, MicroRNA, and Current Bioactive Compounds, along with a book and book chapters published by Cambridge Scholars Publishing and Lambert Academic Publishing. Her research has primarily focused on advanced nanocarrier systems, lipid nanoparticles, drug delivery technologies, and cosmetic formulations. She has also contributed to pharmaceutical innovation through a published patent related to computational prediction of pharmacokinetic and toxicity properties.
Today, the scientific production of Bhawna Sharma consists of more than 15 peer-reviewed publications, a book, international book chapters, a published patent, and several conference presentations, reflecting her growing contributions to pharmaceutical nanotechnology, advanced drug delivery systems, cosmetic science, and formulation research.
Since 2025, Sandip Chatterjee has been serving as Assistant Professor in the Department of Pharmacognosy at SRM Institute of Science and Technology, India. Previously, he served as Assistant Professor at Gopal Narayan Singh University, Bihar, and Sarala Birla University, Jharkhand, and as Lecturer at Pandaveswar School of Pharmacy, West Bengal. He obtained his M.Pharm. in Pharmacognosy (Natural Products Science) from Biju Patnaik University of Technology (BPUT), Rourkela, in 2023 after completing his B.Pharm. from Maulana Abul Kalam Azad University of Technology (MAKAUT), Kolkata. He is currently pursuing his Ph.D. in Pharmaceutical Sciences (Pharmacognosy) at Sanskriti University, India. He has more than four years of teaching and research experience in pharmacognosy, phytochemistry, and natural product research.
His research interests include pharmacognosy, phytochemistry, medicinal plants, natural product drug discovery, herbal medicine, ethnopharmacology, wound healing, phytopharmacology, computational toxicology, antioxidant and antimicrobial studies, and phytochemical characterization. His research particularly focuses on the pharmacological evaluation of medicinal plants, development of herbal formulations, and validation of traditional medicines using modern scientific approaches.
His scientific contributions are documented through numerous peer-reviewed publications in internationally recognized journals, including Current Traditional Medicine, Current Cancer Therapy Reviews, Current Drug Research Reviews, Tropical Journal of Natural Product Research, Indian Drugs, Journal of Natural Remedies, Journal of Applied Pharmaceutical Research, Journal of Applied and Natural Science, Pharmacognosy Research, Micro and Nanosystems, and several other Scopus- and Web of Science-indexed journals. He has also authored books and book chapters in pharmacognosy and natural product sciences and actively serves as a peer reviewer for several international scientific journals.
Today, the scientific production of Sandip Chatterjee consists of more than 15 peer-reviewed publications, books, book chapters, conference papers, and reviewer contributions, reflecting his growing expertise in pharmacognosy, phytochemistry, herbal medicine, ethnopharmacology, and natural product-based drug discovery.
Since 2023, Chandrakant Dixit has been serving as Assistant Professor and Examination Cell Coordinator at Accurate College of Pharmacy, Greater Noida, India. Previously, he served as Assistant Professor at Jeevan Gopi Institute of Pharmacy and Technology, Baghpat, Uttar Pradesh. He obtained his M.Pharm. in Pharmaceutics from I.T.S. College of Pharmacy, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, in 2021 after completing his B.Pharm. from Shri Gopichand College of Pharmacy, AKTU, Lucknow, in 2019. He is currently pursuing his Ph.D. in Pharmacy at Galgotias University, Greater Noida. He has more than four years of teaching and research experience in pharmaceutics and pharmaceutical sciences.
His research interests include pharmaceutical nanotechnology, novel drug delivery systems, formulation development, solubility enhancement techniques, hydrotropic solubilization, computer-aided formulation design, precision medicine, herbal therapeutics, marine bioactive compounds, and pharmaceutical nanomedicine. His research particularly focuses on improving drug solubility, advanced formulation strategies, and nanotechnology-based drug delivery for enhanced therapeutic efficacy.
His scientific contributions are documented through peer-reviewed publications in journals including Current Materials Science, Biochemical and Cellular Archives, Journal of Biomedical and Pharmaceutical Research, International Journal of All Research Education and Scientific Methods, and several other journals, along with book chapters published by Nexus Knowledge Publication and forthcoming contributions to Bentham Science and Springer Nature. He has also contributed to pharmaceutical innovation through a patent on pharmaceutical compositions for sleep disorders and has actively participated in national and international conferences, faculty development programmes, and scientific workshops.
Today, the scientific production of Chandrakant Dixit consists of research articles, review papers, book chapters, a patent, and ongoing research in pharmaceutics and pharmaceutical nanotechnology, reflecting his growing contributions to formulation science, drug delivery systems, pharmaceutical research, and pharmaceutical education.
Since 2022, Nikhil Prem Rajnani has been serving as Assistant Professor at Prin. K. M. Kundnani College of Pharmacy, Mumbai, India. Previously, he worked as Research Associate at Macleods Pharmaceuticals Ltd. from 2018 to 2021, where he gained extensive experience in formulation development, technology transfer, scale-up, stability studies, and regulatory documentation for oral solid dosage forms. He obtained his M.Pharm. in Pharmaceutics from Prin. K. M. Kundnani College of Pharmacy, University of Mumbai, in 2018 after completing his B.Pharm. from the same institution in 2013. He has more than seven years of combined academic, industrial, and pharmaceutical research experience.
His research interests include pharmaceutical nanotechnology, novel drug delivery systems, nanoformulations, nanocochleates, microspheres, targeted drug delivery, pharmaceutical polymers, formulation development, molecular docking, artificial intelligence in drug discovery, computational pharmaceutics, and pharmaceutical documentation. His research integrates formulation science with computational approaches for improving drug solubility, bioavailability, and targeted therapeutic delivery.
His scientific contributions are documented through numerous peer-reviewed publications in internationally recognized journals and books published by Elsevier, Wiley, Taylor & Francis, Academic Press, IGI Global, and other reputed publishers. His work includes research articles, review papers, and book chapters covering nanotechnology, pharmaceutical polymers, computational drug discovery, analytical method development, marine-derived biomaterials, anticancer drug delivery, and herbal therapeutics. He has also contributed to pharmaceutical innovation through multiple Indian patents related to novel drug delivery systems, transdermal formulations, and pharmaceutical compositions.
Today, the scientific production of Nikhil Prem Rajnani consists of more than 15 peer-reviewed publications, several international book chapters, multiple Indian patents, and numerous national and international research awards, reflecting his growing contributions to pharmaceutics, nanotechnology, computational drug discovery, advanced drug delivery systems, and pharmaceutical research.
Since 2022, Shailender Mishra has been serving as Assistant Professor at Sunder Deep Pharmacy College, Ghaziabad, India. Previously, he served as Assistant Professor at Monad University, Hapur, from 2018 to 2022, where he was actively involved in teaching, research, project coordination, placement activities, academic administration, and quality assurance initiatives. He obtained his M.Pharm. in Pharmaceutical Chemistry from Monad University, Hapur, in 2018 after completing his B.Pharm. from the same university in 2016. He has more than six years of teaching and research experience in pharmaceutical sciences.
His research interests include pharmaceutical chemistry, medicinal chemistry, nanotechnology, artificial intelligence in pharmaceutical sciences, molecular docking, drug discovery, pharmaceutical analysis, pharmacovigilance, clinical research, antimicrobial drug development, oral drug delivery systems, and herbal formulations. His research particularly focuses on the synthesis and biological evaluation of novel heterocyclic compounds, AI-assisted pharmaceutical research, nanomedicine, and advanced drug delivery technologies.
His scientific contributions are documented through numerous peer-reviewed research and review publications in journals including Journal of Applied Pharmaceutical Science and Research, Bulletin of Pure and Applied Science, Journal of Experimental Zoology India, International Journal of Pharma Professional Research, International Journal of Novel Research and Development, International Journal of All Research Education and Scientific Methods, International Journal of Creative Research Thoughts, and several edited books on artificial intelligence and pharmaceutical technology. He has also contributed to pharmaceutical innovation through multiple Indian patents and a granted design patent covering pharmaceutical compositions, medical devices, artificial intelligence applications, and novel therapeutic technologies. He actively serves as a reviewer for several international scientific journals and has participated in numerous national and international conferences, faculty development programmes, and professional training programmes.
Today, the scientific production of Shailender Mishra consists of numerous peer-reviewed research and review articles, book chapters, multiple Indian patents, conference presentations, and reviewer contributions, reflecting his growing expertise in pharmaceutical chemistry, medicinal chemistry, nanotechnology, artificial intelligence, drug discovery, and pharmaceutical research.
Since 2025, Shivam Tyagi has been serving as a faculty member at Raj Kumar Goel Institute of Technology, Ghaziabad, India. Previously, he served at Shri Gopichand College of Pharmacy, Baghpat, Uttar Pradesh, from 2024 to 2025. He obtained his M.Pharm. in Pharmaceutics from Raj Kumar Goel Institute of Technology, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, in 2024 after completing his B.Pharm. from Shri Gopichand College of Pharmacy, AKTU, in 2022. His postgraduate research focused on the formulation, characterization, and in vitro evaluation of a Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) of Diflunisal for enhancing drug delivery and therapeutic performance.
His research interests include pharmaceutics, nanotechnology-based drug delivery systems, self-nanoemulsifying drug delivery systems (SNEDDS), pharmacosomes, mucoadhesive drug delivery, pharmaceutical formulation development, digital health technologies, quality assurance, and novel drug delivery strategies. He has practical experience in formulation development, quality control, quality assurance, pharmaceutical manufacturing, dissolution studies, UV-visible spectrophotometry, and hospital pharmacy practices.
His scientific contributions are documented through peer-reviewed publications on advanced drug delivery systems, digital health technologies, medicinal plants, and pharmaceutical innovations. He has authored review articles published in international journals and has research articles and book chapters under consideration with Bentham Science and IntechOpen. He has also actively participated in national and international conferences, workshops, and training programmes focusing on Quality by Design (QbD), pharmaceutical sciences, and drug delivery research.
Today, the scientific production of Shivam Tyagi consists of peer-reviewed research and review articles, book chapter contributions, conference presentations, and ongoing research in advanced pharmaceutical formulations and nanotechnology-based drug delivery systems, reflecting his growing contributions to pharmaceutics, formulation development, and pharmaceutical research.